If you know someone who might be interested in information about ALTABAX and treatment for impetigo,* we invite you to send your friend a message about this Web site.

The information you provide about yourself and your friend on this page is not stored or used in any way by GlaxoSmithKline or any other organization. The message comes directly from you.

Important Safety Information

*ALTABAX is indicated for use in adults and pediatric patients aged 9 months and older for the topical treatment of impetigo (up to 100 cm² in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes.

The most common drug-related adverse reaction was application site irritation (1.4% of patients).

Please see complete Prescribing Information for ALTABAX

Please see additional information for consumers

Your friend's name:
E-mail address:
Your name:
E-mail address: